Posts by tag
global cancer care
Doctor of Hope
How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…
CancerWorld #117 (July 2026)
We often describe progress in oncology through the language of innovation. New drugs. New technologies. New discoveries. Yet scientific breakthroughs rarely change cancer care on their own. They require people willing to pursue difficult ideas, build institutions, challenge accepted thinking,…
Building Beyond the Bedside: Dr Mohamed Emam Sobeih’s Vision for the Future of Oncology
From crowded oncology wards in Cairo to international leadership in cancer education, Dr. Mohamed Emam Sobeih has built a career shaped by one central belief: treating cancer requires more than medicine alone. At the National Cancer Institute Egypt, where Dr…
This is WHO
There is a lot being said about the World Health Organization these days. Criticism. Political tensions. Funding crises. Countries leaving. Endless speculation about what WHO is, what it failed to do, and what it should become. Some of that criticism…
The Unstoppable Jay: Jayasree K. Iyer’s Global Crusade for Equitable Cancer Care
Jayasree K. Iyer doesn’t pause when asked what keeps her awake at night. “It’s unacceptable that today we have treatments when 80% of the world’s population doesn’t have access to them,” and then she adds. “Why are we celebrating progress…
Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach
Dear Readers, Six months ago, we embarked on a journey, ambitious, humbling, and deeply meaningful. In January 2025, CancerWorld, one of Europe’s most prestigious oncology publications, entered a new chapter under the ownership of p53 (OncoDaily). With that acquisition came…
Pooled procurement of drugs saves millions for Indian cancer centres
A pilot project pooling the procurement of cancer drugs has led to cancer institutes in India saving over USS 116 million – an 82% average reduction on the drugs' reference prices. The results of the pilot project, led by Tata…